| |
|
|
|
CASI Pharmaceuticals Inc.  
|
|
5.55 -0.14 (-0.02%) |
09-21 11:26 |
|
Open: |
5.67 |
Pre close: |
5.69 |
Target:
|
8.33 
|
|
High: |
5.67 |
Low: |
5.41 |
Resistance:
|
7.13
8.20
|
|
Volume: |
196,919 |
Market Cap: |
481M |
Support:
|
5.41
4.50
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.66
|
MACD |
MACD(12,26):
|
-0.44 |
|
MA(20): |
6.53 |
Signal(12,26,9): |
-0.32 |
|
MA(100): |
7.01 |
Stochastic Oscillator |
%K(14,3):
|
8.06  |
|
MA(250): |
5.01 |
%D(3): |
7.27 |
|
Average Volume(K) |
3-Month: |
34531
|
52-Week |
High:
|
8.89 |
|
10-Days: |
27946 |
Low: |
1.69 |
|
RSI |
RSI(14):
|
28.16 |
Change(%): |
197.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.230 |
Return on Equity (ttm) |
-31.9 |
Shares Out. (M) |
86.59 |
|
EPS Est. Current Year |
-0.150 |
Return on Assets (ttm) |
-28.7 |
Shares Float (M) |
84.50 |
|
EPS Est. Next Year |
-0.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
22.50 |
|
Forward EPS |
-0.190 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
2907 |
|
Book Value (p.s.) |
6.440 |
EBITDA (p.s.) |
-0.018 |
P/E |
-24.04 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.86 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-11.71 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-26.87 |
P/CF |
-40.89 |
|
|
|
|
|
|
